These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24196134)

  • 21. Characterization of erythromycin-resistant porcine isolates of Campylobacter coli.
    Shin E; Lee Y
    Microb Drug Resist; 2010 Sep; 16(3):231-9. PubMed ID: 20735175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
    Matsuoka M; Narita M; Okazaki N; Ohya H; Yamazaki T; Ouchi K; Suzuki I; Andoh T; Kenri T; Sasaki Y; Horino A; Shintani M; Arakawa Y; Sasaki T
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4624-30. PubMed ID: 15561835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains.
    Pérez-Boto D; López-Portolés JA; Simón C; Valdezate S; Echeita MA
    J Antimicrob Chemother; 2010 Oct; 65(10):2083-8. PubMed ID: 20647243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
    J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
    Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli.
    Cagliero C; Mouline C; Payot S; Cloeckaert A
    J Antimicrob Chemother; 2005 Nov; 56(5):948-50. PubMed ID: 16157618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
    Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 23S rRNA and L22 ribosomal protein are involved in the acquisition of macrolide and lincosamide resistance in Mycoplasma capricolum subsp. capricolum.
    Prats-van der Ham M; Tatay-Dualde J; Gómez-Martín Á; Corrales JC; Contreras A; Sánchez A; de la Fe C
    Vet Microbiol; 2018 Mar; 216():207-211. PubMed ID: 29519518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of domain V in 23S ribosomal RNA of macrolide-resistant Mycoplasma gallisepticum isolates in Egypt.
    Ammar AM; Abd El-Aziz NK; Gharib AA; Ahmed HK; Lameay AE
    J Infect Dev Ctries; 2016 Aug; 10(8):807-13. PubMed ID: 27580325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribosomal mutations in Arcanobacterium pyogenes confer a unique spectrum of macrolide resistance.
    Jost BH; Trinh HT; Songer JG; Billington SJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1021-3. PubMed ID: 14982799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.
    Kimura K; Nagano N; Nagano Y; Suzuki S; Wachino J; Shibayama K; Arakawa Y
    J Antimicrob Chemother; 2013 Mar; 68(3):539-42. PubMed ID: 23111853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France.
    Marchandin H; Jean-Pierre H; Jumas-Bilak E; Isson L; Drouillard B; Darbas H; Carrière C
    Pathol Biol (Paris); 2001 Sep; 49(7):522-7. PubMed ID: 11642013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.
    Malbruny B; Nagai K; Coquemont M; Bozdogan B; Andrasevic AT; Hupkova H; Leclercq R; Appelbaum PC
    J Antimicrob Chemother; 2002 Jun; 49(6):935-9. PubMed ID: 12039885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycoplasma bovis isolates from dairy calves in Japan have less susceptibility than a reference strain to all approved macrolides associated with a point mutation (G748A) combined with multiple species-specific nucleotide alterations in 23S rRNA.
    Sato T; Higuchi H; Yokota SI; Tamura Y
    Microbiol Immunol; 2017 Jun; 61(6):215-224. PubMed ID: 28504455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
    Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples.
    Gossé M; Lysvand H; Pukstad B; Nordbø SA
    J Clin Microbiol; 2016 Oct; 54(10):2563-7. PubMed ID: 27487958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.
    Peric M; Bozdogan B; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1017-22. PubMed ID: 12604536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study.
    Akaike H; Miyashita N; Kubo M; Kawai Y; Tanaka T; Ogita S; Kawasaki K; Nakano T; Terada K; Ouchi K;
    Jpn J Infect Dis; 2012; 65(6):535-8. PubMed ID: 23183207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.